20 results on '"Füle T"'
Search Results
2. Coexistent systemic mastocytosis and essential thrombocythemia complicated with monoclonal gammopathy and hypocomplementaemia
- Author
-
Varkonyi Judit, Rausz Eszter, Pánczél Pál, Sperlagh Melinda, Varga Lilian, Farkas Henriette, Csomor Judit, Füle Tibor, and Karádi István
- Subjects
systemic mastocytosis ,monoclonal gammopathy ,interferon alpha ,hypocomplementaemia ,Medicine - Published
- 2012
- Full Text
- View/download PDF
3. Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts.
- Author
-
Petővári G, Tóth G, Turiák L, L Kiss A, Pálóczi K, Sebestyén A, Pesti A, Kiss A, Baghy K, Dezső K, Füle T, Tátrai P, Kovalszky I, and Reszegi A
- Subjects
- Humans, Syndecan-1, Collagen Type IV, Ecosystem, Fibroblasts, Communication, Proteoglycans, Carcinoma, Hepatocellular genetics, Liver Neoplasms genetics
- Abstract
Tumors are intricate ecosystems where cancer cells and non-malignant stromal cells, including cancer-associated fibroblasts (CAFs), engage in complex communication. In this study, we investigated the interaction between poorly (HLE) and well-differentiated (HuH7) hepatoma cells and LX2 fibroblasts. We explored various communication channels, including soluble factors, metabolites, extracellular vesicles (EVs), and miRNAs. Co-culture with HLE cells induced LX2 to produce higher levels of laminin β1, type IV collagen, and CD44, with pronounced syndecan-1 shedding. Conversely, in HuH7/LX2 co-culture, fibronectin, thrombospondin-1, type IV collagen, and cell surface syndecan-1 were dominant matrix components. Integrins α6β4 and α6β1 were upregulated in HLE, while α5β1 and αVβ1 were increased in HuH7. HLE-stimulated LX2 produced excess MMP-2 and 9, whereas HuH7-stimulated LX2 produced excess MMP-1. LX2 activated MAPK and Wnt signaling in hepatoma cells, and conversely, hepatoma-derived EVs upregulated MAPK and Wnt in LX2 cells. LX2-derived EVs induced over tenfold upregulation of SPOCK1/testican-1 in hepatoma EV cargo. We also identified liver cancer-specific miRNAs in hepatoma EVs, with potential implications for early diagnosis. In summary, our study reveals tumor type-dependent communication between hepatoma cells and fibroblasts, shedding light on potential implications for tumor progression. However, the clinical relevance of liver cancer-specific miRNAs requires further investigation.
- Published
- 2023
- Full Text
- View/download PDF
4. Aberrant Expression of Syndecan-1 in Cervical Cancers.
- Author
-
Karászi K, Vigh R, Máthé M, Fullár A, Oláh L, Füle T, Papp Z, and Kovalszky I
- Subjects
- Adenocarcinoma metabolism, Adenocarcinoma surgery, Adult, Aged, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell surgery, Female, Fibroblasts metabolism, Fibroblasts pathology, Follow-Up Studies, Humans, Middle Aged, Prognosis, Stromal Cells metabolism, Stromal Cells pathology, Survival Rate, Tumor Cells, Cultured, Uterine Cervical Neoplasms metabolism, Uterine Cervical Neoplasms surgery, Adenocarcinoma pathology, Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell pathology, Hysterectomy mortality, Syndecan-1 metabolism, Uterine Cervical Neoplasms pathology
- Abstract
Syndecan-1, is a transmembrane heparan/chondroitin sulfate proteoglycan necessary for cell-cell and cell-matrix interactions. Its decreased level on the cell surface correlates with poor prognosis in several tumor types. Aberrant stromal localization of syndecan-1 is also considered an unfavorable prognostic factor in various human malignancies. In the presented work the question was addressed if changes in syndecan-1 expression are related to the prognosis of cervical cancer. Immunohistochemistry for syndecan-1 extracellular domain was performed on surgical specimens of primary cervical cancer. To follow the communication between tumor cells and stromal fibroblasts, their mono-and co-cultures were studied, detecting the expression of syndecan-1, smooth muscle actin, vimentin, and desmin. Immunohistochemistry of tumorous specimens revealed that while cell surface syndecan-1 expression was reduced on cancer cells, it appeared on the surface of tumor-associated fibroblasts. Until year 7, the cohort with high cell surface syndecan-1 expression had significantly longer survival. No difference in the same time-period could be detected when stromal syndecan-1 expression was analyzed. In vitro analysis revealed, that tumor cells can induce syndecan-1 expression on fibroblast, and fibroblasts showed that fibroblast-like cells are built by two cell types: (a) syndecan-1 positive, cytokeratin negative real fibroblasts, and (b) syndecan-1 and cytokeratin positive epithelial-mesenchymal transformed tumor cells. Syndecan-1 on the surface of cancer cells appears to be a positive prognostic marker. Although syndecan-1 positive fibroblasts promote tumor cell proliferation in vitro, we failed to detect their cancer promoting effect in vivo.
- Published
- 2020
- Full Text
- View/download PDF
5. Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.
- Author
-
Dudás J, Bocsi J, Fullár A, Baghy K, Füle T, Kudaibergenova S, and Kovalszky I
- Subjects
- Carcinoma, Hepatocellular pathology, Cell Cycle drug effects, Cell Proliferation drug effects, DNA Topoisomerases, Type I metabolism, DNA, Neoplasm metabolism, Hep G2 Cells, Heparin pharmacology, Heparitin Sulfate pharmacology, Humans, Liver drug effects, Liver pathology, Liver Neoplasms pathology, Topotecan pharmacology, Carcinoma, Hepatocellular drug therapy, Heparin therapeutic use, Heparitin Sulfate therapeutic use, Liver Neoplasms drug therapy, Topotecan therapeutic use
- Abstract
Topotecan (TpT) is a major inhibitory compound of topoisomerase (topo) I that plays important roles in gene transcription and cell division. We have previously reported that heparin and heparan sulfate (HS) might be transported to the cell nucleus and they can interact with topoisomerase I. We hypothesized that heparin and HS might interfere with the action of TpT. To test this hypothesis we isolated topoisomerase I containing cell nuclear protein fractions from normal liver, liver cancer tissues, and hepatoma cell lines. The enzymatic activity of these extracts was measured in the presence of heparin, liver HS, and liver cancer HS. In addition, topo I activity, cell viability, and apoptosis of HepG2 and Hep3B cells were investigated after heparin and TpT treatments. Liver cancer HS inhibited topo I activity in vitro. Heparin treatment abrogated topo I enzyme activity in Hep3B cells, but not in HepG2 cells, where the basal activity was higher. Heparin protected the two hepatoma cell lines from TpT actions and decreased the rate of TpT induced S phase block and cell death. These results suggest that heparin and HS might interfere with the function of TpT in liver and liver cancer.
- Published
- 2014
- Full Text
- View/download PDF
6. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.
- Author
-
Péterfia B, Füle T, Baghy K, Szabadkai K, Fullár A, Dobos K, Zong F, Dobra K, Hollósi P, Jeney A, Paku S, and Kovalszky I
- Subjects
- Cell Line, Tumor, Cell Movement genetics, Cell Proliferation, Humans, Proto-Oncogene Protein c-ets-1 genetics, Proto-Oncogene Protein c-ets-1 metabolism, Receptor, IGF Type 1 genetics, Receptor, IGF Type 1 metabolism, Syndecan-1 genetics, Syndecan-2 genetics, Cell Movement physiology, Syndecan-1 metabolism, Syndecan-2 metabolism
- Abstract
Syndecans are transmembrane heparan sulphate proteoglycans. Their role in the development of the malignant phenotype is ambiguous and depends upon the particular type of cancer. Nevertheless, syndecans are promising targets in cancer therapy, and it is important to elucidate the mechanisms controlling their various cellular effects. According to earlier studies, both syndecan-1 and syndecan-2 promote malignancy of HT-1080 human fibrosarcoma cells, by increasing the proliferation rate and the metastatic potential and migratory ability, respectively. To better understand their tumour promoter role in this cell line, syndecan expression levels were modulated in HT-1080 cells and the growth rate, chemotaxis and invasion capacity were studied. For in vivo testing, syndecan-1 overexpressing cells were also inoculated into mice. Overexpression of full length or truncated syndecan-1 lacking the entire ectodomain but containing the four juxtamembrane amino acids promoted proliferation and chemotaxis. These effects were accompanied by a marked increase in syndecan-2 protein expression. The pro-migratory and pro-proliferative effects of truncated syndecan-1 were not observable when syndecan-2 was silenced. Antisense silencing of syndecan-2, but not that of syndecan-1, inhibited cell migration. In vivo, both full length and truncated syndecan-1 increased tumour growth and metastatic rate. Based on our in vitro results, we conclude that the tumour promoter role of syndecan-1 observed in HT-1080 cells is independent of its ectodomain; however, in vivo the presence of the ectodomain further increases tumour proliferation. The enhanced migratory ability induced by syndecan-1 overexpression is mediated by syndecan-2. Overexpression of syndecan-1 also leads to activation of IGF1R and increased expression of Ets-1. These changes were not evident when syndecan-2 was overexpressed. These findings suggest the involvement of IGF1R and Ets-1 in the induction of syndecan-2 synthesis and stimulation of proliferation by syndecan-1. This is the first report demonstrating that syndecan-1 enhances malignancy of a mesenchymal tumour cell line, via induction of syndecan-2 expression.
- Published
- 2012
- Full Text
- View/download PDF
7. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
- Author
-
Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, and Tóvári J
- Subjects
- Adult, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell secondary, Disease-Free Survival, ErbB Receptors metabolism, Female, Gene Amplification, Gene Expression Regulation, Neoplastic genetics, Head and Neck Neoplasms mortality, Head and Neck Neoplasms pathology, Humans, Hungary epidemiology, Lymphatic Metastasis, Male, Middle Aged, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins p21(ras), Retrospective Studies, ras Proteins genetics, Carcinoma, Squamous Cell genetics, ErbB Receptors genetics, Head and Neck Neoplasms genetics
- Abstract
The significance of epidermal growth factor receptor (EGFR) signaling is well studied in a number of different tumors, but limited data is available with regard to head and neck squamous cell carcinoma (HNSCC). Since anti-EGFR therapies are currently under investigation in these malignancies as well, comprehensive information about the alteration of EGFR in HNSCC is necessary to design the most appropriate therapeutic protocols. We examined retrospectively the gene copy number of EGFR by FISH and the protein expression by immunohistochemistry using different epitope-specific antibodies in paraffin-embedded primary tumors of five different regions, from 71 HNSCC patients who had not been treated with anti-EGFR therapy. In seven cases corresponding lymph node metastases were also available for comparative analyses. We also determined the mutational status of tyrosine kinase (TK) domain (exon 19 and 21) and the extracellular deletion mutation (vIII) of EGFR, the KRAS mutation at codon 12 and the presence of HPV infection. Eight of the 71 cases (11.3%) showed EGFR gene amplification (most of them localized into the hypopharyngeal region) and the increased gene copy number (amplification+polysomy) was 43.7%. Despite pronounced intratumoral heterogeneity of EGFR protein expression being found, the high EGFR expression correlated with poor prognosis. On the other hand, the phosphorylation of EGFR was associated with prolonged survival. No mutations in the TK domain of EGFR were found in any of the HNSCC patients and only two cases were KRAS mutant at codon 12. We detected vIII deletion mutation of EGFR in 21% of the samples, but there was no statistically significant correlation between the presence of vIII mutant form and patient survival. EGFR vIII mutation was, however, associated with increased gene copy number. Fourteen of 71 cases (19.7%) were HPV-positive and the incidence of infection showed a decreasing tendency from the oral cavity towards the larynx. Interestingly, in contrast to previous findings, we could not observe improved survival in HPV-positive patients compared to non-infected patients, most probably due to the fact that the majority of these HNSCC patients were smokers and alcohol consumers. In conclusion, we found that increased EGFR protein levels and gene copy numbers (not gene amplification alone) have prognostic significance in the investigated HNSCC patient population. However, the relatively high incidence of the EGFR-vIII mutant form warrants careful therapeutic decision-making when choosing between different anti-EGFR treatment options., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
8. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
- Author
-
Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, and Bodoky G
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Gastrointestinal Stromal Tumors metabolism, Humans, Male, Middle Aged, Molecular Targeted Therapy, Polymorphism, Single Nucleotide, Proto-Oncogene Proteins c-kit metabolism, Receptor, Platelet-Derived Growth Factor alpha metabolism, Gastrointestinal Stromal Tumors genetics, Mutation, Proto-Oncogene Proteins c-kit genetics, Receptor, Platelet-Derived Growth Factor alpha genetics, TOR Serine-Threonine Kinases metabolism
- Abstract
The therapy for gastrointestinal stromal tumors (GISTs) has been revolutionized by tyrosin kinase inhibitors. Clinicopathologic studies have been conducted to assess therapeutical responses in cases with KIT and platelet-derived growth factor receptor α (PDGFRA) gene mutations. Cell culture data suggest that Akt/mammalian target of rapamycin (mTOR) kinase signaling may be important in GIST. The aim of our study was to determine the activity of the mTOR pathway in a larger series of GISTs (108 different cases) with different exon mutation types. The KIT and/or PDGFRA mutation status of 108 GIST patients was analyzed by direct DNA sequencing. Immunohistochemistry was performed on tissue microarrays using antibodies for phospho-p70S6 kinase, phospho-4EBP1, and phospho-S6, which are downstream target proteins of mTOR. DNA sequencing identified 73 cases with mutations of KIT and 12 cases with PDGFRA mutations. Wild-type receptors were present in 23 cases. KIT exon mutations were accompanied by the activation of the mTOR pathway in 28 of 73 (38.4%) cases, whereas PDGFRA mutant GISTs showed activation in 10 of 12 (83.3%) cases. Wild-type cases were accompanied by mTOR activation in 17 of 23 (73.9%) cases. Our results indicate that the activation of the mTOR pathway is not a general hallmark of GIST with KIT mutations. However, mTOR signaling seems to be activated in PDGFRA mutants and in wild-type cases, which suggests that mTOR or upstream mTOR inhibitors may be therapeutically useful in primary resistant GISTs and confirms earlier data that mTOR is a crucial survival pathway in resistant GISTs.
- Published
- 2011
- Full Text
- View/download PDF
9. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
- Author
-
Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, and Sápi Z
- Subjects
- Adolescent, Adult, Aged, Antigens, CD genetics, Antigens, CD metabolism, Antigens, Differentiation, Myelomonocytic genetics, Antigens, Differentiation, Myelomonocytic metabolism, Centromere metabolism, Chi-Square Distribution, Chromosomes, Human, Pair 11, Comparative Genomic Hybridization, Female, Giant Cell Tumor of Bone metabolism, Giant Cell Tumor of Bone pathology, Humans, In Situ Hybridization, Fluorescence, Male, Middle Aged, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Telomere genetics, Telomere metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, beta Catenin genetics, beta Catenin metabolism, Bone Neoplasms genetics, Genomic Instability, Giant Cell Tumor of Bone genetics, Ploidies
- Abstract
Genetic instability in relation to clinical behavior was studied in 52 cases of giant cell tumor of bone (GCTB). Ploidy was determined in the mononuclear cell population by using native cell smears and image cytometry. A relocalization technique allowed fluorescent in situ hybridization (FISH) analysis of CD68-negative neoplastic cells for numerical changes of chromosomes X, 3, 4, 6, 11, and telomeric association on 11p. Genome-wide alterations were tested using array comparative genomic hybridization (array-CGH) on magnetically separated CD68-negative tumor cells. CTNNB1, TP53, and BCL2 protein expression was also analyzed in formol-paraffin sections to see if their pathways are involved in the development of chromosomal instability. CD68-positive histiocytes showed no significant numerical chromosome and telomeric alterations. Based on ploidy values and clinical outcome, we could distinguish five groups as follows: diploid nonrecurrent (n = 20), tetraploid nonrecurrent (n = 6), diploid recurrent (n = 5), tetraploid and/or aneuploid recurrent (n = 14), and malignant cases (n = 7). Random individual-cell aneusomy was significantly (P < 0.001) more frequent in the recurrent groups (36.01 +/- 11.94%) than in the benign nonrecurrent cases (10.65 +/- 3.66%). The diploid recurrent group showed significantly (P < 0.001) increased balanced aneusomy compared with the diploid nonrecurrent group and the tetraploid nonrecurrent group represented eusomic polysomy. Array-CGH and FISH showed clonal aberrations almost exclusively in the malignant group. None of the protein markers tested showed significant correlation with elevated aneuploidy/polysomy (P = 0.56). Our results show that ploidy determination combined with FISH analysis may help predicting recurrence potential of GCTB and suggest that chromosomal abnormalities superimposed on telomeric associations could be responsible for an aggressive clinical course.
- Published
- 2009
- Full Text
- View/download PDF
10. Keratin-positive gastrointestinal stromal tumor of the stomach mimicking gastric carcinoma: diagnosis confirmed by c-kit mutation analysis.
- Author
-
Lippai N, Füle T, Németh T, Benedek G, Mályi I, Pádi E, and Sápi Z
- Subjects
- Carcinoma diagnosis, DNA Mutational Analysis, Diagnosis, Differential, Exons, Female, Gastrointestinal Stromal Tumors chemistry, Gene Deletion, Humans, Middle Aged, Proto-Oncogene Proteins c-kit analysis, Sequence Deletion, Stomach Neoplasms chemistry, Gastrointestinal Stromal Tumors diagnosis, Gastrointestinal Stromal Tumors pathology, Keratins analysis, Proto-Oncogene Proteins c-kit genetics, Stomach Neoplasms pathology
- Abstract
In routine practice, gastrointestinal stromal tumor (GIST) can usually be identified with relative ease on the basis of a rather simple immunohistochemical panel besides its characteristic morphology. Still, serious differential diagnostic problems may arise because of the heterogeneity of these tumors in both morphologic appearance and clinical behavior. In our case, we present a metastatic, ulcerative, hemorrhagic GIST with epithelioid appearance, which displayed diffuse pan cytokeratin (AE1/AE3) positivity beside CD117 expression. As carcinomas may also be CD117-positive, definitive diagnosis was confirmed by the detection of a hexanucleotide deletion in the exon 11 of c-kit. This case demonstrates that although gastric carcinoma more commonly ulcerates or causes hemorrhage than GIST, keratin-positive GIST should also be considered from a differential diagnostic point of view. In these cases, c-kit mutation analysis may be necessary.
- Published
- 2008
- Full Text
- View/download PDF
11. Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive.
- Author
-
Kulka J, Kovalszky I, Svastics E, Berta M, and Füle T
- Subjects
- Adult, Breast Neoplasms pathology, Breast Neoplasms surgery, Carcinoma pathology, Carcinoma surgery, Cell Nucleus pathology, Cell Nucleus virology, DNA, Neoplasm analysis, DNA, Viral analysis, Female, Genes, Viral genetics, Herpesvirus 4, Human genetics, Herpesvirus 4, Human isolation & purification, Human papillomavirus 18 genetics, Humans, Papillomavirus Infections pathology, Papillomavirus Infections surgery, Breast Neoplasms virology, Carcinoma virology, Human papillomavirus 18 isolation & purification, Papillomavirus Infections virology
- Abstract
Lymphoepithelioma-like carcinoma of the breast is a rare tumor, with fewer than 20 cases documented in the literature. None of the published cases was Epstein-Barr virus positive, and our case was also Epstein-Barr virus negative. However, in our case, human papilloma virus (HPV) types 18 and 33 DNA could be demonstrated within the tumor tissue. Many years previously, the patient underwent hysterectomy for cervical carcinoma in situ which showed the presence of HPV-33. To the best of our knowledge, this is the first report on lymphoepithelioma-like carcinoma of the breast where high-risk HPV infection may be suggested as an etiological factor in a patient with a previous history of cervical carcinoma in situ.
- Published
- 2008
- Full Text
- View/download PDF
12. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
- Author
-
Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, and Romics I
- Subjects
- Aged, Chromosomes, Human, Pair 6 genetics, DNA, Neoplasm genetics, Female, Humans, Loss of Heterozygosity, Male, Sensitivity and Specificity, Urinary Bladder Neoplasms genetics, DNA, Neoplasm blood, DNA, Neoplasm urine, Microsatellite Repeats genetics, Urinary Bladder Neoplasms diagnosis
- Abstract
The accumulation of genetic alterations plays a role in the evolution of bladder cancer. These changes can be detected in the urine by DNA analysis of the cells exfoliated from the bladder wall enabling us to detect bladder cancer. The urine supernatant, besides the urine sediment, contains DNA, however in a much smaller amount. The origin of DNA in these two fractions is probably different. Our aim was to evaluate which fraction (supernatant or sediment) provides more reliable results in detecting tumors. We analyzed blood, urine and tumor samples taken from 80 individuals (44 patients with bladder cancer, 20 control patients and 16 healthy volunteers) by using 12 microsatellite markers mapped on 6 chromosomes. Microsatellite alterations were detected in the urine sediment and supernatant in 86% of the cancer cases. Urine sediment alone had a sensitivity of 68%, while urine supernatant alone indicated aberrations in 80% of the tumors. In the superficial (Ta/T1) cases, a considerable difference in sensitivity, 84 vs. 67%, was found between the two fractions in favor of urine supernatant. We also detected deletions in the control groups, although in a much lower proportion. Loss of the 16q24 chromosomal region showed a significant correlation with tumor stage (p=0.02). Microsatellite analysis of the urine is an efficient and noninvasive molecular method to detect bladder cancer. The analysis of free DNA in the urine supernatant provides a higher detection rate. The marker on the chromosomal region 16q24 is suggested to have a prognostic value.
- Published
- 2007
13. Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis.
- Author
-
Csire M, Mikala G, Jákó J, Masszi T, Jánosi J, Dolgos J, Füle T, Tordai A, Berencsi G, and Vályi-Nagy I
- Subjects
- Adult, Antiviral Agents therapeutic use, Disease Progression, Histiocytosis, Langerhans-Cell pathology, Histiocytosis, Langerhans-Cell virology, Humans, Langerhans Cells pathology, Langerhans Cells virology, Male, Roseolovirus Infections drug therapy, Roseolovirus Infections pathology, Herpesvirus 6, Human pathogenicity, Histiocytosis, Langerhans-Cell complications, Roseolovirus Infections etiology
- Abstract
Langerhans cell histiocytosis (eosinophilic granuloma) was first diagnosed in the adolescence of a male patient presented. Several years later persisting human herpesvirus 6 (HHV-6) infection was recognized. The HHV-6 infection could be verified retrospectively in his historical histological samples; the continuous presence of HHV-6 could be established through 17 years of disease course. The patient was operated several times during this period for painful relapses, and developed diabetes insipidus. At variable time points during the clinical course, Varicella zoster (VZV), Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8) infections were temporarily detected from blood samples and biopsy specimens. HHV-6 was the only virus continuously identified throughout the entire follow-up period. Antiviral therapy effectively cleared EBV and HHV-8, but HHV-6 remained detectable throughout the disease course. Since DNA sequences of HHV-6 could be detected in the pathologic histiocytes of eosinophilic granuloma, and from other samples taken later on, it is suggested that long-term HHV-6 infection may be associated with development or progression of Langerhans cell histiocytosis.
- Published
- 2007
- Full Text
- View/download PDF
14. The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.
- Author
-
Füle T, Máthé M, Suba Z, Csapó Z, Szarvas T, Tátrai P, Paku S, and Kovalszky I
- Subjects
- Base Sequence, DNA, Viral genetics, DNA, Viral isolation & purification, Female, Head and Neck Neoplasms blood supply, Head and Neck Neoplasms virology, Human papillomavirus 16 genetics, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Oncogene Proteins, Viral genetics, Oncogene Proteins, Viral metabolism, Papillomavirus E7 Proteins, Papillomavirus Infections virology, Peripheral Nerves virology, Repressor Proteins genetics, Repressor Proteins metabolism, Uterine Cervical Neoplasms blood supply, Uterine Cervical Neoplasms virology, Endothelium, Vascular virology, Human papillomavirus 16 isolation & purification, Human papillomavirus 16 pathogenicity, Neurons virology
- Abstract
Human papillomavirus (HPV) is known as a strictly epitheliotropic pathogen. Our results raised the possibility that HPV 16 is present in neural cells and in the vascular endothelium. By in situ hybridization, we have detected HPV 16 E6 ORF sequence in small blood vessels and peripheral nerves adjacent to oral and cervical cancers. The same structures have clearly shown immunohistochemical reactivity for the E6 oncoprotein. These results were verified by PCR applied to E6 and L1 ORFs following microscopic laser dissection of the immunohistochemically positive nerves and vessels. These observations suggest that HPV 16 DNA and protein are present in neurons and endothelial cells in the vicinity of HPV-associated tumors. The HPV 16 genome presumably exists in a non-replicating form in the neurons and constitutively produces high levels of E6 and E7 proteins with an unknown neuropathological outcome.
- Published
- 2006
- Full Text
- View/download PDF
15. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.
- Author
-
Máthé M, Suba Z, Németh Z, Tátrai P, Füle T, Borgulya G, Barabás J, and Kovalszky I
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell secondary, Carcinoma, Squamous Cell therapy, Female, Humans, Immunoenzyme Techniques, Male, Middle Aged, Mouth Neoplasms pathology, Mouth Neoplasms therapy, Neoplasm Proteins metabolism, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Stromal Cells metabolism, Survival Analysis, Tongue Neoplasms metabolism, Tongue Neoplasms pathology, Tongue Neoplasms therapy, Treatment Outcome, Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell metabolism, Mouth Neoplasms metabolism, Syndecan-1 metabolism
- Abstract
Syndecan-1, a transmembrane proteoglycan, may exert anti-proliferative effects and promote cell growth by binding various growth factors. Malignant epithelial cells often down-regulate their own syndecan-1 production, and are capable of inducing an aberrant syndecan-1 expression in stromal fibroid cells. Decreased tumor cell syndecan-1 levels in human head and neck squamous cell carcinomas indicate poor prognosis, however, no correlation between stromal syndecan-1 expression and clinical parameters has previously been established. By means of immunohistochemistry, we observed a decrease in tumor cell syndecan-1 reactivity in 33/39 oral carcinoma cases, the degree of which, however, correlated only weakly with the clinical outcome (p = 0.097). Conversely, stromal syndecan-1 positivity proved to be a significant risk factor of recurrence (Cox analysis, p = 0.03) and tumor-specific death (p = 0.023) within a 24-month period after operation. Taken together, stromal expression of syndecan-1 is a reliable factor of adverse prognosis in oral carcinomas.
- Published
- 2006
- Full Text
- View/download PDF
16. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
- Author
-
Füle T, Csapó Z, Máthé M, Tátrai P, László V, Papp Z, and Kovalszky I
- Subjects
- Adult, Aged, DNA, Viral analysis, Female, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local virology, Neoplasm Staging, Polymerase Chain Reaction, Prognosis, Lymph Nodes pathology, Lymph Nodes virology, Papillomaviridae genetics, Papillomavirus Infections complications, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms virology
- Abstract
Objective: In this study, we investigated the presence of high-risk (HR) HPV types most prevalent in the Hungarian population in surgically removed cervical cancers and pelvic lymph nodes. The aim of our work was to determine the prognostic significance of HPV status in the lymph nodes draining the tumor., Methods: Primary tumor specimens from 150 patients and 900 lymph node samples (six per case) were studied. Fifty-six/150 were early (FIGO IA-IB) stage, while 94/150 were advanced (FIGO IIA-IIIB) stage cancers. Beside histopathological evaluation, DNA extracted from the tissue samples was subjected to nested PCR to detect characteristic type-specific sequences of HPVs 16, 18 and 33. Moreover, clinicopathological data were collected for an average 48-month postoperative follow-up period for the purposes of statistical analysis., Results: The presence of HR-HPV types in the lymph nodes shows no correlation with disease-free survival, whereas the presence of lymph node metastases significantly decreases life expectancy (P = 0.002). Lymph nodes with metastases more frequently carry HR-HPV than nodes with no evidence of tumorous infiltration (65% versus 36%, P < 0.001); however, a high number of metastases surrounding HR-HPV-positive tumors were found negative for the viruses (42/120)., Conclusions: HR-HPV status of pelvic lymph nodes draining cervical cancers has no noticeable influence on the life expectancy of the patients. HR-HPV-positive tumor cells do not necessarily have a selective advantage in forming metastases. Presumably, a number of alterations in cellular genes rather than the presence of papillomavirus DNA may have a decisive role in the progression of cervical cancers.
- Published
- 2006
- Full Text
- View/download PDF
17. Comparative detection of high-risk HPV (16, 18, 33) in cervical bioptic material of county hospital of Tg. Mures.
- Author
-
Pávai Z, Füle T, Horváth E, Máthé M, Pap Z, Denes L, and Jung J
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy, Cohort Studies, Female, Hospitals, County, Humans, Middle Aged, Papillomavirus Infections epidemiology, Papillomavirus Infections etiology, Papillomavirus Infections virology, Retrospective Studies, Risk Factors, Romania, Uterine Cervical Neoplasms epidemiology, Uterine Cervical Neoplasms virology, Uterine Cervical Dysplasia epidemiology, Uterine Cervical Dysplasia virology, Cervix Uteri virology, Human papillomavirus 16 isolation & purification, Human papillomavirus 18 isolation & purification
- Abstract
The purpose of this study was to collect data about the incidence of high-risk HPV (16, 18, 33) types in paraffin embedded cervical bioptic material, including LSIL, HSIL and cervical cancers using immunohistochemistry and nested PCR methods. In our study were included randomly selected 10 LSIL, 18 HSIL and 30 cervical cancer cases. We analyzed the expression of HPV in this specimens with immunohistochemistry used DAKO K1H8 antibody and CHEMICON Mab HPV 16, 16 antibody using LSAB method and Tiramin amplification method, and nested PCR for HPV 16, 18 and 33. In LSIL cases three, in HSIL cases eight and in carcinoma 20 cases were positive for HPV 16 or 18 for immunohistochemistry or PCR. Although this proportion in lower than those reported in the literature, our work signals the existence of the infection in our country and presents a relatively cheap diagnostic method.
- Published
- 2006
18. Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection.
- Author
-
Lotz G, Simon S, Patonai A, Sótonyi P, Nemes B, Sergi C, Glasz T, Füle T, Nashan B, and Schaff Z
- Subjects
- Adult, Aged, Antibodies, Monoclonal, Antigens, Bacterial analysis, Chlamydophila pneumoniae genetics, Chlamydophila pneumoniae immunology, Chronic Disease, Cytomegalovirus genetics, DNA, Bacterial analysis, DNA, Viral analysis, Female, Foam Cells pathology, Hepatic Artery microbiology, Hepatocytes microbiology, Humans, Immunohistochemistry methods, Liver pathology, Male, Middle Aged, Polymerase Chain Reaction, Portal System microbiology, Staining and Labeling, Chlamydophila pneumoniae isolation & purification, Graft Rejection microbiology, Liver microbiology, Liver Transplantation
- Abstract
Background: Chlamydia pneumoniae is one of the possible pathogenetic factors of atherosclerotic processes. Foam cell arteriopathy is a generally accepted pathologic feature of chronic liver allograft rejection and has several similarities to the early lesions of atherosclerosis. The aim of the authors' study was to show any existing correlation between the occurrence of Chlamydia pneumoniae and the presence of foam cell arteriopathy in transplanted livers with chronic rejection., Methods: Ten liver samples from patients with chronic liver rejection including foam cell arteriopathy and 10 liver samples from healthy individuals were analyzed for the presence of Chlamydia pneumoniae by specific immunohistochemistry and polymerase chain reaction (PCR). Liver samples from two transplant patients with chronic liver rejection without any evidence of foam cell arteriopathy and nine patients with acute liver allograft rejection were also investigated by PCR., Results: In all 10 rejected liver samples, Chlamydia pneumoniae was detected by PCR, whereas only one of the healthy control samples and one of the samples with acute rejection were found to be positive. Immunohistochemistry showed similar results. The positive signals of Chlamydia pneumoniae were localized mainly in the hepatocytes, sinusoidal and perisinusoidal cells, and the cells of portal tracts, whereas most of the altered hepatic arteries showed no or very weak positivity., Conclusions: The results strongly suggest an association between the occurrence of Chlamydia pneumoniae and the presence of foam cell arteriopathy in transplanted livers.
- Published
- 2004
- Full Text
- View/download PDF
19. [The molecular diagnostics of viruses].
- Author
-
Füle T and Kovalszky I
- Subjects
- Animals, Biomarkers, Tumor genetics, Blotting, Northern, Blotting, Southern, DNA, Neoplasm genetics, DNA, Viral genetics, Diagnosis, Differential, Humans, In Situ Hybridization, Neoplasms diagnosis, Neoplasms genetics, Oncogene Proteins, Viral genetics, Polymerase Chain Reaction, Sensitivity and Specificity, Tumor Virus Infections complications, Biomarkers, Tumor analysis, DNA, Neoplasm analysis, DNA, Viral analysis, Neoplasms virology, Nucleic Acid Amplification Techniques methods, Oncogene Proteins, Viral analysis, Tumor Virus Infections diagnosis, Tumor Virus Infections genetics
- Abstract
For many years data of cancer research indicated that viruses can cause cancer. Virus infections induce cancer by different mechanisms. To predict the significance of a viral DNA fragment in human cells we have to be aware of the changes the particular virus is able to induce there.However, no matter which mechanisms of viral carcinogenesis are utilized, generally other factors (environmental, chemical, immunodeficiency, etc.) are also needed to induce invasive cancer in human. Before the introduction of nucleic acid based detection technique virus identification was a long and cumbersome process. This has been eliminated by the invention of recombinant gene technology and polymerase chain reaction. Virus nucleic acid can be detected without amplification using Southern, Northern and in situ hybridization. Techniques for target (polymerase chain reaction)or signal (hybrid capture, tyramine) amplification improved the sensitivity of detection. In the meantime, for the successful use of the arsenal of new methods we have to consider the characteristic feature of molecular virus research. A major achievement of molecular virus detection is that it proved the pathological significance of viruses in human cancers even in those where this was not expected. Hopefully these informations will increase the effort for elimination of oncogene virus infections.
- Published
- 2002
- Full Text
- View/download PDF
20. Detection of high-risk HPV (16, 18, 33) in situ cancer of the cervix by PCR technique.
- Author
-
Pete I, Szirmai K, Csapó Z, Szánthó A, Füle T, Gallai M, and Kovalszky I
- Subjects
- Biopsy, Needle, Blotting, Southern, Carcinoma in Situ virology, Chi-Square Distribution, Colposcopy, Culture Techniques, Female, Humans, In Situ Hybridization, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Sensitivity and Specificity, Uterine Cervical Neoplasms virology, Carcinoma in Situ pathology, Papillomaviridae classification, Papillomavirus Infections pathology, Polymerase Chain Reaction, Tumor Virus Infections pathology, Uterine Cervical Neoplasms pathology
- Abstract
Objective: The purpose of this study was to collect data about the incidence of high-risk HPV (16, 18, 33) types in in situ cervical cancers, and to evaluate the reliability of the morphological signs of HPV infection by comparing the presence of these signs to the PCR-proven HPV virus infection., Methods: Fifty patients who underwent conisation at the Department of Obstetrics and Gynecology of Semmelweis University, Budapest, Hungary because of in situ cervical cancer were examined retrospectively for the presence of HPV infection by the PCR technique. The direct and indirect morphological signs of HPV infection identified in the histological and cytological samples were compared to the actual results of virus DNA amplification by PCR in the identical histological sections. The evaluation of the cytological smears and the histological sections was accomplished independently by two different pathologists., Results: E6 open reading frame of HPV 16, 18 or 33 was detected by PCR in 56% (28 cases) of the histological sections of the 50 examined patients with in situ cancer. In 92% (26 patients) of the 28 HPV positive patients one HPV type was detected, while in one of the remaining two cases two HPV types (16/33), or all three types could be detected. The direct morphological signs for HPV infection proved to be 75% sensitive and 50% specific when compared to the results of PCR. Their predictive value for HPV infection was 65%. For the indirect HPV signs the sensitivity was 64% and specificity 31%. The predictive value, prognosticating the presence of HPV 16, 18, 33 infection was 54% in the same sections. Using significance analysis no significant relationship (p = 0.7728) could be detected between the positivity of indirect signs and the presence of HPV 16, 18, 33 infection, while in case of direct signs the relationship was almost significant (p = 0.0675). The joint testing of the direct and indirect signs did not improve the results (p = 0.1338). During the review of the cytological smears the specificity of the cytology in predicting true HPV infections was found to be 68% and sensitivity was 20%. The predictive value was only 50%. A significance analysis was not accomplished by this diagnostic method because of the missing data (see text)., Conclusion: The method of Nawa et al. seems to be a reliable approach for the detection of HPV DNA in paraffin-embedded material. The three main types of HPV (16, 18, 33) are probably represented in lower percentages in CIN III in Hungary, but a larger survey is needed to obtain reliable data. The direct and indirect morphological signs of HPV infection failed to show a significant relationship with the PCR proven presence of HPV 16, 18, 33.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.